76P Relative dose-intensity of trabectedin and outcome of advanced L-sarcomas

Stephen Poitureau; M. Le Deley; M. Brahmi; Emmanuelle Bompas; J.E. Kurtz; Simon Nannini; Christophe Perrin; Loïc Lebellec; Thomas Ryckewaert; Romain Ould-Ammar; Clémence Leguillette; Jean Yves Blay; N. Penel

doi:10.1016/j.esmoop.2025.104390

Article2025

Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas

Stephen Poitureau, Marie‐Cécile Le Deley, Mehdi Brahmi, Emmanuelle Bompas, Jean‐Emmanuel Kurtz, Simon Nannini, Christophe Perrin, Loïc Lebellec, Thomas Ryckewaert, Romain Ould-Ammar, Clémence Leguillette, Jean Yves Blay, Nicolas Penel

Article2020

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas

Javier Martín‐Broto, Nadia Hindi, Antonio López–Pousa, J. Peinado, Rosa Álvarez, Ana Álvarez-González, Antoîne Italiano, Paul Sargos, Josefina Cruz Jurado, J. Isern, Maria Carmen Dolado, Inmaculada Rincon-Pérez, Paloma Sánchez-Bustos, Antonio Gutiérrez, Cleofé Romagosa, Carlo Morosi, Giovanni Grignani, Marco Gatti, Pablo Luna, I. Alastuey, Andrés Redondo, Belén Belinchón, Jordi Martínez-Serra, Marie‐Pierre Sunyach, Jean‐Michel Coindre, Angelo Paolo Dei Tos, Jesús Romero, Alessandro Gronchi, Jean Yves Blay, David S. Moura

Article2023

76P Relative dose-intensity of trabectedin and outcome of advanced L-sarcomas

Discussion(0)

Related publications

Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas

Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

Data from Body Composition, Relative Dose Intensity, and Adverse Events among Patients with Colon Cancer

Data from Body Composition, Relative Dose Intensity, and Adverse Events Among Patients with Colon Cancer